WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Broker-Dealer
  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Investment Adviser
  • Israel
  • Latin America
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • Decarbonization Strategies
  • Energy Regulation and Competition
  • Project Development and Transactions
  • Project Finance and Tax Equity
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • National Security
  • Payments
  • Privacy and Cybersecurity
  • Strategic Risk and Crisis Management

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Merger Clearance
  • Antitrust Litigation
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • FoodTech and AgTech
  • Fintech and Financial Services
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Semiconductors
  • Software

  • Offices
  • Events
  • Pro Bono
  • Community
  • Our Diversity
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Beijing
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • SOMA
  • Washington, D.C.
  • Wilmington, DE

  • Law Students + Recent Graduates
  • Experienced Attorneys
  • Patent Agents
  • Professional Staff
  • Alternative Legal Careers
  • Contact Recruiting

Antitrust Compliance and Business Strategy

Open PDF
  • Critical Legal Counsel

    Wilson Sonsini provides strategic legal and compliance advice to established technology and life sciences companies, as well as growing innovators.

Our team provides extensive compliance and strategic business advice to clients on antitrust issues involved in the licensing of intellectual property, as well as classic antitrust issues associated with the pricing, distribution, and advertising of products. Examples of situations in which we have provided compliance and/or strategic counseling to clients include the following:

IP Licensing

Our clients are leading developers of IP across a range of industries, including the pharmaceutical, medical device, software, and hardware sectors. Working with the firm’s technology transactions practice—the largest of its kind in the United States—Wilson Sonsini’s antitrust team advises clients on the full gamut of IP licensing practices, including how to bundle licenses with services, cross-license IP to competitors, and enter exclusive IP licensing arrangements. For example, we have counseled biotech companies on the tying of reagents to patent licenses for such reagents; pharmaceutical companies on the tying of diagnostic equipment to drugs; and software companies on the tying of operating systems to applications.

Standard Setting and Patent Pooling

We have counseled companies that are organizing to form standard-setting bodies, as well as clients participating in standards associations. Examples include advising companies on their IP disclosure obligations to standard-setting organizations that they have contemplated entering and setting up bylaws for some of the more significant organizations in which our clients participate.

We also represent companies seeking to collaborate to facilitate the wide adoption of new technologies through patent-pooling arrangements. We have counseled clients on how to structure the arrangement, appoint neutral experts to evaluate the necessity of adding patents to the pool, and set appropriate royalty rates, taking into consideration the complex antitrust rules governing this practice.

Pricing and Distribution

We regularly assist our clients with the adoption of new pricing, distribution, and advertising policies. We have advised clients on pricing and commercial strategies (including establishing resale pricing programs); on structuring distribution, licensing, and supply agreements (including the termination of distributors and suppliers); and on establishing and maintaining antitrust compliance procedures (including for Sarbanes-Oxley purposes).

Overview

Our team provides extensive compliance and strategic business advice to clients on antitrust issues involved in the licensing of intellectual property, as well as classic antitrust issues associated with the pricing, distribution, and advertising of products. Examples of situations in which we have provided compliance and/or strategic counseling to clients include the following:

IP Licensing

Our clients are leading developers of IP across a range of industries, including the pharmaceutical, medical device, software, and hardware sectors. Working with the firm’s technology transactions practice—the largest of its kind in the United States—Wilson Sonsini’s antitrust team advises clients on the full gamut of IP licensing practices, including how to bundle licenses with services, cross-license IP to competitors, and enter exclusive IP licensing arrangements. For example, we have counseled biotech companies on the tying of reagents to patent licenses for such reagents; pharmaceutical companies on the tying of diagnostic equipment to drugs; and software companies on the tying of operating systems to applications.

Standard Setting and Patent Pooling

We have counseled companies that are organizing to form standard-setting bodies, as well as clients participating in standards associations. Examples include advising companies on their IP disclosure obligations to standard-setting organizations that they have contemplated entering and setting up bylaws for some of the more significant organizations in which our clients participate.

We also represent companies seeking to collaborate to facilitate the wide adoption of new technologies through patent-pooling arrangements. We have counseled clients on how to structure the arrangement, appoint neutral experts to evaluate the necessity of adding patents to the pool, and set appropriate royalty rates, taking into consideration the complex antitrust rules governing this practice.

Pricing and Distribution

We regularly assist our clients with the adoption of new pricing, distribution, and advertising policies. We have advised clients on pricing and commercial strategies (including establishing resale pricing programs); on structuring distribution, licensing, and supply agreements (including the termination of distributors and suppliers); and on establishing and maintaining antitrust compliance procedures (including for Sarbanes-Oxley purposes).

Newsletters
2022 Antitrust Year in Review
We are proud to share the 2022 Antitrust Year in Review, which discusses significant developments in antitrust law, policy, and enforcement over the past year. First, the report spotlights recent outcomes in court for U.S. agency enforcement litigation and discusses major changes in the law that create substantial new antitrust obligations, as well as updated policy and enforcement guidelines. Then, the merger enforcement section describes significant merger control activity by enforcers in the U.S., EU, and UK, and the civil conduct enforcement section outlines enforcer activity in investigating and challenging non-merger conduct. Finally, the report provides an update on global cartel enforcement policy and activity, and concludes with a survey of significant private antitrust litigation in the United States and UK.
Alerts
U.S. Legislators and State Attorneys General Raise Antitrust Concerns Regarding ESG Collaborations
Over the past year, U.S. legislators and state attorneys general (AGs) have raised concerns that collaborations among firms to achieve environmental, social, and governance (ESG) goals are violations of the antitrust laws. As a result, ESG collaborations may face oversight hearings in the U.S. House of Representatives and additional investigations from state AGs. Accordingly, companies should ensure any ESG collaborations they undertake anticipate possible antitrust issues in the United States. By contrast, the European Union is shifting towards a more flexible approach for ESG collaborations.
Alerts
FTC Reinterprets FTC Act to Include Broad Powers Related to “Interlocking Directorates”
In what might be a further expansion of antitrust enforcement of interlocking directorates, the Federal Trade Commission (FTC) issued a policy statement announcing that it now interprets Section 5 of the FTC Act to grant it authority to take enforcement action against interlocking directorates or officers of competing firms that do not fall within the “literal language of the Clayton Act.”1
Alerts
DOJ Obtains First Criminal Guilty Plea for Monopolization Conduct in Decades
The Antitrust Division of the U.S. Department of Justice (DOJ) suggested at the beginning of the year that it would consider criminally prosecuting monopolization conduct—a departure from antitrust enforcement of the past several decades.1 The DOJ has now done so. On October 31, 2022, Nathan Zito, president of Z&Z Asphalt (Z&Z), a paving and asphalt contractor, pleaded guilty to violating Section 2 of the Sherman Act by attempting to monopolize the markets for highway crack-sealing services in Montana and Wyoming.2
Alerts
Seven Directors Resign from Five Public Company Boards
Last month, we reported that the U.S. Department of Justice (DOJ) had threatened multiple public companies, private equity investors, and individuals with lawsuits for violating the ban on interlocking directorates under Section 8 of the Clayton Act. Section 8 prohibits the same firm or individual from sitting on the boards of competing companies. The DOJ based its claim of alleged violations on information that it gleaned from SEC filings, earnings calls, and other public sources.
Alerts
DOJ Launches Enforcement Initiative Against “Interlocking Directorates”
In what appears to be a significant expansion of its antitrust enforcement efforts, the U.S. Department of Justice (DOJ) issued letters to multiple public companies, investors, and individuals this week, stating it may bring lawsuits against them for maintaining “interlocking directorates” in violation of Section 8 of the Clayton Antitrust Act (15 U.S.C. § 19).
View All
Insights
Newsletters
2022 Antitrust Year in Review
We are proud to share the 2022 Antitrust Year in Review, which discusses significant developments in antitrust law, policy, and enforcement over the past year. First, the report spotlights recent outcomes in court for U.S. agency enforcement litigation and discusses major changes in the law that create substantial new antitrust obligations, as well as updated policy and enforcement guidelines. Then, the merger enforcement section describes significant merger control activity by enforcers in the U.S., EU, and UK, and the civil conduct enforcement section outlines enforcer activity in investigating and challenging non-merger conduct. Finally, the report provides an update on global cartel enforcement policy and activity, and concludes with a survey of significant private antitrust litigation in the United States and UK.
Alerts
U.S. Legislators and State Attorneys General Raise Antitrust Concerns Regarding ESG Collaborations
Over the past year, U.S. legislators and state attorneys general (AGs) have raised concerns that collaborations among firms to achieve environmental, social, and governance (ESG) goals are violations of the antitrust laws. As a result, ESG collaborations may face oversight hearings in the U.S. House of Representatives and additional investigations from state AGs. Accordingly, companies should ensure any ESG collaborations they undertake anticipate possible antitrust issues in the United States. By contrast, the European Union is shifting towards a more flexible approach for ESG collaborations.
Alerts
FTC Reinterprets FTC Act to Include Broad Powers Related to “Interlocking Directorates”
In what might be a further expansion of antitrust enforcement of interlocking directorates, the Federal Trade Commission (FTC) issued a policy statement announcing that it now interprets Section 5 of the FTC Act to grant it authority to take enforcement action against interlocking directorates or officers of competing firms that do not fall within the “literal language of the Clayton Act.”1
Alerts
DOJ Obtains First Criminal Guilty Plea for Monopolization Conduct in Decades
The Antitrust Division of the U.S. Department of Justice (DOJ) suggested at the beginning of the year that it would consider criminally prosecuting monopolization conduct—a departure from antitrust enforcement of the past several decades.1 The DOJ has now done so. On October 31, 2022, Nathan Zito, president of Z&Z Asphalt (Z&Z), a paving and asphalt contractor, pleaded guilty to violating Section 2 of the Sherman Act by attempting to monopolize the markets for highway crack-sealing services in Montana and Wyoming.2
Alerts
Seven Directors Resign from Five Public Company Boards
Last month, we reported that the U.S. Department of Justice (DOJ) had threatened multiple public companies, private equity investors, and individuals with lawsuits for violating the ban on interlocking directorates under Section 8 of the Clayton Act. Section 8 prohibits the same firm or individual from sitting on the boards of competing companies. The DOJ based its claim of alleged violations on information that it gleaned from SEC filings, earnings calls, and other public sources.
Alerts
DOJ Launches Enforcement Initiative Against “Interlocking Directorates”
In what appears to be a significant expansion of its antitrust enforcement efforts, the U.S. Department of Justice (DOJ) issued letters to multiple public companies, investors, and individuals this week, stating it may bring lawsuits against them for maintaining “interlocking directorates” in violation of Section 8 of the Clayton Antitrust Act (15 U.S.C. § 19).
View All
Jeffrey C. Bank
Partner
Washington, D.C.
Jeff represents companies in antitrust disputes, including multi-district litigations and cartel cases.
  • Antitrust and Competition
View Profile
Beau Buffier
Partner
Boston
Beau Buffier is an antitrust partner in the Boston and New York offices of Wilson Sonsini Goodrich & Rosati, where his practice focuses on defending clients in merger investigations before the Federal Trade Commission and Department of Justice as well as non-U.S. antitrust agencies including the CMA (UK). Beau also represents domestic and foreign clients in connection with various antitrust issues concerning cartel matters, abuse of dominance, joint ventures, distribution arrangements, intellectual property, competitor collaborations and Hart-Scott-Rodino compliance. Beau has defended substantive merger investigations and other civil and criminal investigations involving a wide variety of industries, including semiconductors, telecommunications, enterprise software, internet platforms, pharmaceuticals, medical devices, chemicals, retailing, airlines, automotive parts, and entertainment and ticketing.
  • Antitrust and Competition
View Profile
Susan Creighton
Partner
Washington, D.C.
Susan focuses on merger review, government investigations, and antitrust litigation and counseling.
  • Antitrust and Competition
View Profile
Michelle Yost Hale
Partner
Washington, D.C.
Michelle Hale is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on representing companies in government antitrust investigations, including mergers and acquisitions and other civil antitrust investigations. She regularly appears before the Federal Trade Commission (FTC) and the U.S. Department of Justice, representing companies across a range of industries. Michelle also provides antitrust counseling on a wide variety of business conduct, including joint ventures, collaborations, and pricing and distribution, among others.
  • Antitrust and Competition
View Profile
Jindrich Kloub
Partner
Brussels
Jindrich Kloub is a partner in the Brussels office of Wilson Sonsini Goodrich & Rosati, where he focuses on competition and antitrust matters, including civil and criminal enforcement efforts and investigations.
  • Antitrust and Competition
View Profile
Ben Labow
Partner
San Francisco
Ben advises clients on antitrust issues, such as M&A clearance, pricing, and distribution.
  • Antitrust and Competition
View Profile
Kenneth O'Rourke
Partner
Washington, D.C.
Ken represents companies in antitrust litigation, including complex cases and high-stakes disputes litigated in the U.S. and abroad.
  • Antitrust and Competition
View Profile
Chul Pak
Partner
New York
Chul represents manufacturers, services companies, and technology firms in antitrust litigation, mergers, and counseling.
  • Antitrust and Competition
View Profile
Mark R. Rosman
Partner
Washington, D.C.
Mark represents clients in antitrust matters, including cartel defense, enforcement investigations, and merger and civil non-merger cases.
  • Antitrust and Competition
View Profile
Franklin M. Rubinstein
Partner
Washington, D.C.
Franklin advises clients on antitrust matters, including merger review, government and criminal investigations, litigation, and antitrust-related counseling. 
  • Antitrust and Competition
View Profile
View All
People
Jeffrey C. Bank
Partner
Washington, D.C.
Jeff represents companies in antitrust disputes, including multi-district litigations and cartel cases.
  • Antitrust and Competition
View Profile
Beau Buffier
Partner
Boston
Beau Buffier is an antitrust partner in the Boston and New York offices of Wilson Sonsini Goodrich & Rosati, where his practice focuses on defending clients in merger investigations before the Federal Trade Commission and Department of Justice as well as non-U.S. antitrust agencies including the CMA (UK). Beau also represents domestic and foreign clients in connection with various antitrust issues concerning cartel matters, abuse of dominance, joint ventures, distribution arrangements, intellectual property, competitor collaborations and Hart-Scott-Rodino compliance. Beau has defended substantive merger investigations and other civil and criminal investigations involving a wide variety of industries, including semiconductors, telecommunications, enterprise software, internet platforms, pharmaceuticals, medical devices, chemicals, retailing, airlines, automotive parts, and entertainment and ticketing.
  • Antitrust and Competition
View Profile
Susan Creighton
Partner
Washington, D.C.
Susan focuses on merger review, government investigations, and antitrust litigation and counseling.
  • Antitrust and Competition
View Profile
Michelle Yost Hale
Partner
Washington, D.C.
Michelle Hale is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on representing companies in government antitrust investigations, including mergers and acquisitions and other civil antitrust investigations. She regularly appears before the Federal Trade Commission (FTC) and the U.S. Department of Justice, representing companies across a range of industries. Michelle also provides antitrust counseling on a wide variety of business conduct, including joint ventures, collaborations, and pricing and distribution, among others.
  • Antitrust and Competition
View Profile
Jindrich Kloub
Partner
Brussels
Jindrich Kloub is a partner in the Brussels office of Wilson Sonsini Goodrich & Rosati, where he focuses on competition and antitrust matters, including civil and criminal enforcement efforts and investigations.
  • Antitrust and Competition
View Profile
Ben Labow
Partner
San Francisco
Ben advises clients on antitrust issues, such as M&A clearance, pricing, and distribution.
  • Antitrust and Competition
View Profile
Kenneth O'Rourke
Partner
Washington, D.C.
Ken represents companies in antitrust litigation, including complex cases and high-stakes disputes litigated in the U.S. and abroad.
  • Antitrust and Competition
View Profile
Chul Pak
Partner
New York
Chul represents manufacturers, services companies, and technology firms in antitrust litigation, mergers, and counseling.
  • Antitrust and Competition
View Profile
Mark R. Rosman
Partner
Washington, D.C.
Mark represents clients in antitrust matters, including cartel defense, enforcement investigations, and merger and civil non-merger cases.
  • Antitrust and Competition
View Profile
Franklin M. Rubinstein
Partner
Washington, D.C.
Franklin advises clients on antitrust matters, including merger review, government and criminal investigations, litigation, and antitrust-related counseling. 
  • Antitrust and Competition
View Profile
View All
Related Practices
  • Antitrust and Competition
Recent Insights
Newsletters
2022 Antitrust Year in Review
We are proud to share the 2022 Antitrust Year in Review, which discusses significant developments in antitrust law, policy, and enforcement over the past year. First, the report spotlights recent outcomes in court for U.S. agency enforcement litigation and discusses major changes in the law that create substantial new antitrust obligations, as well as updated policy and enforcement guidelines. Then, the merger enforcement section describes significant merger control activity by enforcers in the U.S., EU, and UK, and the civil conduct enforcement section outlines enforcer activity in investigating and challenging non-merger conduct. Finally, the report provides an update on global cartel enforcement policy and activity, and concludes with a survey of significant private antitrust litigation in the United States and UK.
Learn More
Alerts
U.S. Legislators and State Attorneys General Raise Antitrust Concerns Regarding ESG Collaborations
Over the past year, U.S. legislators and state attorneys general (AGs) have raised concerns that collaborations among firms to achieve environmental, social, and governance (ESG) goals are violations of the antitrust laws. As a result, ESG collaborations may face oversight hearings in the U.S. House of Representatives and additional investigations from state AGs. Accordingly, companies should ensure any ESG collaborations they undertake anticipate possible antitrust issues in the United States. By contrast, the European Union is shifting towards a more flexible approach for ESG collaborations.
Learn More
View All
Newsletters
2020 Antitrust Year in Review
Our antitrust practice is pleased to present a report summarizing the most significant antitrust matters and developments of the past year. The publication examines the final year of antitrust enforcement under the Trump administration, analyzes actions by U.S. antitrust agencies and enforcers in other jurisdictions worldwide across a range of merger review, civil conduct, and criminal enforcement matters; and highlights new guidance issued by U.S. agencies and developments in the treatment of efficiencies in merger analysis. It also notes areas of cooperation and contention between U.S. agencies, examines the DOJ’s enforcement agenda and leniency program, and offers an update on private antitrust litigation, among other content.
Read the 2020 Antitrust Year in Review
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Employee Login
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2023 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.